Quadrature Capital’s Shattuck Labs STTK Stock Holding History

Quadrature Capital’s Portfolio STTK Stock Details STTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,134	Closed	-$78K	–	2034
2026 Q1	$78K	Buy	+12,134	New	+$57.6K	﹤0.01%	1254

Other funds holding STTK

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

NCM

NEXTBio Capital Management Menlo Park, California $217M AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quadrature Capital's STTK Position: Q2 2026 in Review

Quadrature Capital sold out of Shattuck Labs (STTK) in Q2 2026, closing a stake of 12,134 shares — an estimated $78K sold.

Quadrature Capital first reported a position in STTK in Q1 2026 and held it in 1 quarter. The position peaked at $78K in Q1 2026. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

Quadrature Capital reported no remaining Shattuck Labs position as of Q2 2026 after selling out during the quarter.
Quadrature Capital sold 12,134 Shattuck Labs shares in Q2 2026, an estimated $78K.
Quadrature Capital first reported a position in Shattuck Labs in Q1 2026 and held it in 1 quarter.
Quadrature Capital's Shattuck Labs position peaked at $78K in Q1 2026.
100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.